In analyses excluding early follow-up data, there was also no significant between-group difference in the incidence of invasive cancer of any type or major cardiovascular events. A post hoc analysis of the rate of death from cancer suggested a possible benefit with respect to the rate of total deaths from cancer after exclusion of early follow-up data, based on an unadjusted 95% confidence interval that does not include 1.